14 February 2022 - PHARMAC has issued a consultation today on proposals to widen access to two medicines, rituximab and zoledronic ...
26 August 2021 - PHARMAC is considering awarding Principal Supply to a biosimilar brand of adalimumab (Amgevita) from 1 February ...
22 June 2021 - PHARMAC is seeking additional feedback on a proposal to change the funded brands of primidone tablets ...
26 February 2021 - PHARMAC is seeking feedback on a proposal to increase the subsidy to fully fund ethinyloestradiol 20 ...
4 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to rituximab. ...
12 November 2020 - PHARMAC is seeking feedback on a proposal to widen access to valganciclovir. ...
2 October 2020 - PHARMAC is seeking feedback on a proposal to widen funded access to sirolimus from 1 February ...
18 September 2020 - PHARMAC is seeking feedback on a proposal to fund emicizumab (Hemlibra), a new treatment for people with ...
11 August 2020 - As part of PHARMAC’s Annual Tender process, PHARMAC is proposing to list two new medicines on ...
30 July 2020 - PHARMAC is seeking feedback on a proposal to fund an additional brand (DuoResp Spiromax) of two ...
2 July 2020 - PHARMAC is pleased to announce a decision to: ...
21 May 2020 - PHARMAC is proposing to award sole supply of infliximab, a biologic medicine used to treat a ...
2 April 2020 - PHARMAC is seeking feedback on a proposal to fund a new modified-release granule formulation of pancreatic ...
24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) ...
20 January 2020 - The TGA is undertaking a consultation through its website to seek stakeholder's views on TGA’s proposed fees ...